DaShenLin Pharmaceutical Group Co (SHSE:603233) ROCE % : 14.09% (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DaShenLin Pharmaceutical Group Co's annualized ROCE % for the quarter that ended in Sep. 2023 was 14.09%.

DaShenLin Pharmaceutical Group Co ROCE % Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co ROCE % Chart

DaShenLin Pharmaceutical Group Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

25.00

24.42

20.98

12.96

13.74

DaShenLin Pharmaceutical Group Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															13.07	2.11	25.78	20.44	14.09

DaShenLin Pharmaceutical Group Co ROCE % Calculation

DaShenLin Pharmaceutical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	1463.129	/	( ( (17335.682 - 7175.606)	+	(20841.243 - 9707.603) )	/ 2 )
	=	1463.129	/	( (10160.076	+	11133.64)	/ 2 )
	=	1463.129	/	10646.858
	=	13.74 %

DaShenLin Pharmaceutical Group Co's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	1700.848	/	( ( (20831.059 - 8880.156)	+	(21432.129 - 9233.326) )	/ 2 )
	=	1700.848	/	( ( 11950.903	+	12198.803 )	/ 2 )
	=	1700.848	/	12074.853
	=	14.09 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

DaShenLin Pharmaceutical Group Co (SHSE:603233) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DaShenLin Pharmaceutical Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of DaShenLin Pharmaceutical Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000

Website

http://www.dslyy.com

DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Headlines

No Headlines